DALKEMPY

Serial Number 98373312
688

Registration Progress

Application Filed
Jan 24, 2024
Under Examination
Feb 25, 2025
Approved for Publication
Dec 31, 2024
Published for Opposition
Dec 31, 2024
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Aug 25, 2025 40 days

Trademark Image

DALKEMPY

Basic Information

Serial Number
98373312
Filing Date
January 24, 2024
Published for Opposition
December 31, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
688
Status Date
Feb 25, 2025
Application
Pending
Classes
005

Rights Holder

Sage Therapeutics Inc.

03
Address
55 Cambridge Parkway
Suite 401
Cambridge, MA 02142

Ownership History

Sage Therapeutics Inc.

Original Applicant
03
Cambridge, MA

Sage Therapeutics Inc.

Owner at Publication
03
Cambridge, MA

Legal Representation

Attorney
Steven A. Abreu

USPTO Deadlines

Next Deadline
40 days remaining
NOA E-Mailed - SOU Required
Due Date
August 25, 2025
Extension Available
Until February 25, 2026

Application History

19 events
Date Code Type Description Documents
Mar 25, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Mar 25, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Mar 25, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Feb 25, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Dec 31, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 31, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 25, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 9, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 29, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 26, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 26, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 9, 2024 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Sep 9, 2024 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Jun 11, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 11, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 11, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 11, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
May 26, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 24, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for use in the treatment of central nervous system diseases and disorders, neurological diseases and disorders

Classification

International Classes
005